Categories
News

LATEST NEWS: COVID-19 Impact on Personalized Cancer Vaccines Market Report Insights, Forecast, Share Analysis – Neon Therapeutics, Moderna, Inc., Gritstone Oncology

The Personalized Cancer Vaccines Market report has been produced with the systematic gathering and analysis of information about individuals or organizations conducted through social and opinion research. This wide-reaching Personalized Cancer Vaccines Market advertising report comprises of all the organization profiles of the key players and brands. With the studies, insights and analysis mentioned in the report, comprehensible idea about the marketplace can be obtained with which business decisions can be taken quickly and easily. This document is a detailed portrayal of the market scenarios which introduces a mix of research mastery and business methodologies. Every possible effort has been taken into account while investigating and scrutinizing data to set up this Personalized Cancer Vaccines Market research report.

The major competitors currently working in the personalized cancer vaccines market: Neon Therapeutics, Moderna, Inc., Merck & Co., Inc., Gritstone Oncology, Personalis Inc, Genocea Biosciences, Inc., F. Hoffmann-La Roche Ltd, CureVac AG, Celldex Therapeutics, BioNTech SE, Advaxis, Inc, and among others.

Get a sample copy of report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-personalized-cancer-vaccines-market

Personalized Cancer Vaccines Market to grow with a substantial CAGR in the forecast period of 2019-2026 Growing rate of prevalence rate of cancer and accelerating demand of novel therapies to prevent of cancer related disorders are the key factors for lucrative growth of market.

Global Personalized Cancer Vaccines Market

By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma),

By Mechanism of action Type (Tumor-associated antigens (TAAs), Tumor-specific antigens (TSAs), Somatic Mutations in Cancer Pharmacogenomics, Pharmacogenomics towards Genomic Polymorphism),

By Biomaker Type (Pharmacogenomic, Prognostic and Predictive Biomarkers, Immune Checkpoint Biomarkers and Others),

By therapy Type (Immunotherapy),

By Route of Administration (Injectabls),

By End- users (Hospitals, Homecare, Specialty Clinics, Others),

By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Definition: Global Personalized Cancer Vaccines Market

Personalized cancer vaccines are the type of immunotherapy that boosts the immune system to fight against a cancerous cell. These types of vaccine are tailored to match a patient’s particular tumor cell after received cancer related surgery. This vaccine may prevent from cancer, destroy cancer cells and inhibit the growth of tumors cells.

According to the article published in The American Cancer Society, it was identified that the total incidence of cancer in the United States in the year 2018 were1, 735,350 and  609,640 patients die from cancer in the same year. Growing rate of incidence rate of cancer and accelerating demand of novel therapies to prevent of cancer related disorders are the key factors for lucrative growth of market.

Market Drivers

  • Increases cases of cancer globally
  • Growing demand of personalized cancer vaccine production
  • Government initiatives and assistance for cancer related preventions
  • Robust pipeline of novel therapies under clinical development
  • Increase in strategic collaboration between the companies

Market Restraints

  • High cost involved in the treatment
  • Scientific and major technical challenges for production of personalized cancer vaccine
  • Inadequate awareness about personalized cancer vaccine in some developing countries

Make an Inquiry Before Buying @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-personalized-cancer-vaccines-market

Segmentation: Global Personalized Cancer Vaccines Market

By Cancer Type

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Leukemia
  • Prostate Cancer
  • Cervical Cancer
  • Glioblastoma
  • Other

By Mechanism of action Type

  • Tumor-associated antigens (TAAs)
  • Tumor-specific antigens (TSAs)
  • Somatic Mutations in Cancer Pharmacogenomics
  • Pharmacogenomics towards Genomic Polymorphism

By Biomaker Type

  • Pharmacogenomic Biomarkers
  • Prognostic and Predictive Biomarkers
  • Immune Checkpoint Biomarkers
  • Others

By Route of administration

  • Injectables

 By End users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific
  • Middle East & Africa
    • South Africa
    • Egypt
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Rest of Middle East & Africa

Key Developments in the Market:

In March 2019, Neon Therapeutics, Inc. investigating NEO-PV-01, a novel personalized cancer vaccine cells in a combination with nivolumab that targeting neoantigens and kills their cancer cells.

In September 2016, BioNTech AG and Genentech, Inc. has entered into research collaboration for the development of messenger RNA (mRNA)-based, individualized cancer vaccines for the treatment of broad range of cancer. As per the deal, BioNTech AG receive USD 310 million as a upfront payment and eligible to receive milestone payment.

In June 2016, Moderna, Inc and Merck & Co., Inc entered into research collaboration for the development of mRNA-based personalized cancer vaccines in a combination with keytruda (pembrolizumab) for the treatment of multiple types of tumor. As per the deal, Moderna, Inc. will receive USD 200 million from Merck & Co., Inc. as upfront payment.

Competitive Analysis: 

Global personalized cancer vaccines market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of personalized cancer vaccines market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of Global Personalized Cancer Vaccines Market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-personalized-cancer-vaccines-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

Leave a Reply

Your email address will not be published. Required fields are marked *